Efficacy and Safety of Bromfenac Ophthalmic Solution in Cataract Surgery

Completed · Phase 3 · Has a placebo group

Conditions studied: Cataract

In brief

Efficacy and Safety of Bromfenac Ophthalmic Solution in Cataract Surgery

Key facts

Study ID

NCT00704418

Run by

Bausch & Lomb Incorporated

People needed

156

Starts

2008-06-01

Expected to finish

2009-12-01

Last updated by the study team

2013-01-18

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Scheduled for cataract surgery

You may not qualify if…

• Known hypersensitivity to bromfenac and salicylates

Where it is running

• ISTA Pharmaceuticals, Inc. — Irvine, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.